Phase II randomised placebo-controlled trial of sodium selenate as a disease-modifying treatment in chronic drug-resistant temporal lobe epilepsy: the SeLECT study protocol.

Lucy E VivashHannah JohnsLeonid ChurilovSara MacPhailPablo Casillas-EspinosaCharles MalpasSandy R ShultzChris TailbyManori WijayathDavid ReutensLisa GillinderPiero PeruccaPatrick CarneyJohn-Paul NicoloNicholas LawnPatrick KwanDennis VelakoulisChristopher M HovensTerence J O'Brien

Published in: BMJ open (2023)

ANZCTR; ACTRN12623000446662.

Keyphrases

drug resistant
phase ii
open label
clinical trial
study protocol
double blind
placebo controlled
temporal lobe epilepsy
multidrug resistant
acinetobacter baumannii
randomized controlled trial
phase iii
combination therapy
cystic fibrosis